ABOUT THE WORKSHOP SERIES

The U.S. Trade and Development Agency (USTDA) in collaboration with the Corporate Council on Africa (CCA) presents a Workshop Series on Regulatory Convergence for Healthcare Products in Africa.

In this series, we will host four distinct, regionally focused workshops that will set the stage and lead up to a final continent-wide workshop. Each workshop will include a dedicated day for pharmaceutical products and another dedicated day for medical devices. These sessions will convene a select group of key stakeholders, including pharmaceutical and medical device companies, trade associations from both the United States and Africa, as well as regulatory authorities and government agencies from both regions. The primary objective is to foster discussions on the most effective regulatory practices for pharmaceuticals and medical devices, with the overarching goal of promoting harmonization with international standards and achieving convergence in healthcare regulatory systems.

Through this series, we aim to:

  • Promote increased collaboration between regulatory authorities and industry.
  • Facilitate broader market access for healthcare products while enhancing the quality and availability of pharmaceuticals and medical devices across the continent.
  • Improve application and approval timelines/processes.
  • Provide a platform for participants to network and exchange ideas, experiences, and best practices for strengthening regulatory systems in Africa.

MEET HEALTH REGULATORY DECISION-MAKERS FROM

WEST AFRICA

The U.S. Trade and Development Agency (USTDA) will host the second event in its workshop series on Regulatory Convergence for Healthcare Products in Africa on July 16 - 17, 2024 at the Transcorp Hilton Hotel in Abuja, Nigeria. This workshop series is organized by the Corporate Council on Africa and includes five regionally focused workshops that convene pharmaceutical and medical device companies, U.S. and African government representatives and multilateral partners to discuss best practices and identify practical steps needed to strengthen regulatory systems and improve market access for essential medical products in Africa.

This workshop will spotlight the developments and successes of the ZAZIBONA program, which recently celebrated 10 years of operation. Panel discussions will also focus on what’s next for regulatory harmonization in the SADC region. For medical devices, attention will be given to navigating medical devices regulatory pathways from the perspectives of innovators, local manufacturers, importers and other stakeholders in the value chain. Outcomes of the workshop will be action-oriented and contribute towards the culmination of a continental view of regulatory harmonization for pharmaceuticals and medical devices.

WHY YOU SHOULD ATTEND

  • Explore lessons learned from the experience of WAHO and other key regulatory agencies in the region.
  • Learn how technology can improve communication, regulatory process efficiency, transparency and governance.
  • Participate in B2B and B2G discussions about what is needed to accelerate the transition to continent wide harmonization.
  • Discover sustainable financing models for regulatory harmonization.
  • Understand the differences between regulations for medical devices and pharmaceuticals.
  • See live demonstrations of medical devices to show regulatory diversity.
  • Case studies on pharmaceuticals regulatory review in the region.

July 16 - 17, 2024

DAY 1: 9:00 AM - 6:00 PM

DAY 2: 9:00 AM - 5:00 PM

Transcorp Hilton Abuja

 Abuja, Nigeria

Confirmed Speakers

 

U.S. and African Government Officials:

  • Prof. Moji Adeyeye, Director General, National Agency for Food and Drug Administration Control, Nigeria (NAFDAC)
  • Alex Juma Ismail, Program Officer, AUDA-NEPAD
  • Heather Lanigan, Regional Director for Sub-Saharan Africa, U.S. Trade and Development Agency (USTDA)
  • Dr. Oumy Ndiaye, Director General, The Department of Pharmacy and Laboratories (DPL), Senegal
  • Emmanuel Nkrumah, Director Medical Devices, Cosmetic & Household Chemicals, Ghana FDA
  • Enoch Nyarko, Head of Unit, IVD/MD, Ghana FDA
  • Joseph Rieras, J.D., Director of the Office of Trade and Global Partnerships (OTGP) US FDA 

 

Private Sector:

  • Mirette Abskharoun, Associate Director Regulatory Affairs at Johnson & Johnson for Middle East &Africa (MEA), Johnson & Johnson 
  • Dr. Simon Agwale, CEO, Innovative Biotech Nigeria
  • Dr. Kwesi Amissah-Arthur, Founder and Director, Quintex Pharma Inc,
  • Dr. Zainab Bagudu, CEO, Medicaid Diagnostics and Medicaid Cancer Foundation 
  • Sharika Baijnath, Regulatory Affairs Manager, Africa and EWBU, Rapid Diagnostics Division, Abbott
  • Dr. Kwasi Boateng, Director U.S. Pharmacopeia (USP) 
  • Rana Chalhoub, Regulatory Affairs Director, Mecomed
  • Prof. Rotimi Jaiyesimi MBBS, FRCOG, FWACS, FRSPH, MFCI, MBA, SFFMLM, LL.M (Medical Law),  Mobihealth 
  • Bukola Johnson, Snr Specialist, Regulatory Affairs Pharmacist, West Africa & QPPV for Nigeria, MSD
  • Steve Kipkoti, Senior Regulatory Affairs Specialist, Medtronic
  • Chris LeGrand, CEO, BroadReach Group
  • Philana Mugyenyi, Director, Government Affairs & Market Access, Sub-Saharan Africa
  • Puvi Naidoo, Head of Regulatory Affairs, Pfizer Laboratories
  • Kirti Narsai, Senior Advisor, Corporate Council on Africa (CCA) 
  • Khatija Suleman, Head of Regulatory Affairs, Becton Dickinson & Co 

For more information, please contact:

Morayor Essieh

messieh@corporatecouncilonafrica.com